[PCRX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
28-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -1,357.72%
YoY- -96.96%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 163,926 169,467 160,341 171,955 167,466 169,411 157,991 2.48%
PBT 16,601 37,854 -26,474 -18,068 2,069 22,007 7,294 72.93%
Tax 5,743 12,091 -6,938 -7,966 2,762 2,131 466 432.72%
NP 10,858 25,763 -19,536 -10,102 -693 19,876 6,828 36.20%
Tax Rate -34.59% -31.94% - - -133.49% -9.68% -6.39% -
Total Cost 153,068 143,704 179,877 182,057 168,159 149,535 151,163 0.83%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 6.62 15.20 -12.18 -5.87 -0.41 11.73 4.32 32.88%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS 0.23 0.56 -0.43 -0.22 -0.02 0.40 0.15 32.93%
EPS Diluted 0.23 0.49 -0.43 -0.22 -0.02 0.38 0.15 32.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.